Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Knapp

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1989
[3H]-[H-D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2] ([3H]CTOP), a potent and highly selective peptide for mu opioid receptors in rat brainK N Hawkins, R J Knapp, G K Lui, et al.
Life Sciences|May 19, 2001
Mutation W284L of the human delta opioid receptor reveals agonist specific receptor conformations for G protein activationY Hosohata, E V Varga, D Stropova, et al.
Biochemical and Biophysical Research Communications|November 14, 1991
Topographical requirements for delta opioid ligands: presence of a carboxyl group in position 4 is not critical for deltorphin high delta receptor affinity and analgesic activityA Misicka, A W Lipkowski, L Fang, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1991
[D-Pen2,4'-125I-Phe4,D-Pen5]enkephalin: a selective high affinity radioligand for delta opioid receptors with exceptional specific activityR J Knapp, S D Sharma, G Toth, et al.
Journal of Medicinal Chemistry|March 19, 1993
Design and synthesis of highly potent and selective cyclic dynorphin A analogs. 2. New analogsA M Kawasaki, R J Knapp, T H Kramer, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 13, 2022
Cost-Effectiveness of Midazolam Versus Haloperidol Versus Olanzapine for the Management of Acute Agitation in the Accident and Emergency DepartmentVincent K C Yan, Miriam Haendler, Hayden Lau, et al.
European Journal of Pharmacology|March 16, 1993
Unexpected antinociceptive potency of cyclic [D-Tca1]CTAP: potential for a novel mechanism of actionP J Horan, K D Wild, W M Kazmierski, et al.
European Journal of Pharmacology|May 12, 1997
Relative efficacies of delta-opioid receptor agonists at the cloned human delta-opioid receptorR M Quock, Y Hosohata, R J Knapp, et al.
Molecular Pharmacology|December 1, 1996
The third extracellular loop of the human delta-opioid receptor determines the selectivity of delta-opioid agonistsE V Varga, X Li, D Stropova, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1996
Structure-activity relationships for SNC80 and related compounds at cloned human delta and mu opioid receptorsR J Knapp, G Santoro, I A De Leon, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1989
[3H]-[H-D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2] ([3H]CTOP), a potent and highly selective peptide for mu opioid receptors in rat brainK N Hawkins, R J Knapp, G K Lui, et al.
Life Sciences|May 19, 2001
Mutation W284L of the human delta opioid receptor reveals agonist specific receptor conformations for G protein activationY Hosohata, E V Varga, D Stropova, et al.
Biochemical and Biophysical Research Communications|November 14, 1991
Topographical requirements for delta opioid ligands: presence of a carboxyl group in position 4 is not critical for deltorphin high delta receptor affinity and analgesic activityA Misicka, A W Lipkowski, L Fang, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1991
[D-Pen2,4'-125I-Phe4,D-Pen5]enkephalin: a selective high affinity radioligand for delta opioid receptors with exceptional specific activityR J Knapp, S D Sharma, G Toth, et al.
Journal of Medicinal Chemistry|March 19, 1993
Design and synthesis of highly potent and selective cyclic dynorphin A analogs. 2. New analogsA M Kawasaki, R J Knapp, T H Kramer, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 13, 2022
Cost-Effectiveness of Midazolam Versus Haloperidol Versus Olanzapine for the Management of Acute Agitation in the Accident and Emergency DepartmentVincent K C Yan, Miriam Haendler, Hayden Lau, et al.
European Journal of Pharmacology|March 16, 1993
Unexpected antinociceptive potency of cyclic [D-Tca1]CTAP: potential for a novel mechanism of actionP J Horan, K D Wild, W M Kazmierski, et al.
European Journal of Pharmacology|May 12, 1997
Relative efficacies of delta-opioid receptor agonists at the cloned human delta-opioid receptorR M Quock, Y Hosohata, R J Knapp, et al.
Molecular Pharmacology|December 1, 1996
The third extracellular loop of the human delta-opioid receptor determines the selectivity of delta-opioid agonistsE V Varga, X Li, D Stropova, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1996
Structure-activity relationships for SNC80 and related compounds at cloned human delta and mu opioid receptorsR J Knapp, G Santoro, I A De Leon, et al.
Pageof 5